Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
NCT ID: NCT02160340
Last Updated: 2018-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1584 participants
OBSERVATIONAL
2014-05-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
NCT00417846
Non-invasive Optical Angiography in Age-related Macular Degeneration
NCT02521142
Single In-Clinic Encounter With the Notal Vision Home OCT
NCT04642183
Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration
NCT02941263
Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA
NCT03415984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitreomacular adhesion
Male or female subjects aged over 40 years with vitreomacular adhesion
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Dense media opacity
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ThromboGenics
INDUSTRY
Carl Zeiss Meditec, Inc.
INDUSTRY
Optovue
INDUSTRY
Nova Southeastern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie A Rodman, OD, MS, FAAO
Role: PRINCIPAL_INVESTIGATOR
Nova Southeastern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schaeffer Eye Center
Birmingham, Alabama, United States
Leo Semes
Birmingham, Alabama, United States
Schwartz Laser Eye Center
Scottsdale, Arizona, United States
VA Greater Los Angeles Healthcare System
Sepulveda, California, United States
Front Range Eye Associates
Broomfield, Colorado, United States
Aran Eye Associates
Coral Gables, Florida, United States
Nova Southeastern University
Fort Lauderdale, Florida, United States
Retina Macula Specialists of Miami
Miami, Florida, United States
Murray Ocular Oncology and Retina
Miami, Florida, United States
Vitreous and Retina Consultants
Winter Haven, Florida, United States
Clayton Eye Center
Morrow, Georgia, United States
Indiana University College of Optometry
Indianapolis, Indiana, United States
Grin Eyecare
Olathe, Kansas, United States
Jones Eyecare
Albuquerque, New Mexico, United States
Pacific University College of Optometry
Portland, Oregon, United States
Larry Alexander
McKinney, Texas, United States
Retina and Macula Specialists
Tacoma, Washington, United States
Suburban Opticians
University Place, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11221319Exp
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.